To include your compound in the COVID-19 Resource Center, submit it here.

Secnidazole: Phase I data

An open-label Phase I trial in 54 healthy female volunteers showed that co-administration of a single dose

Read the full 174 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE